Filing Details

Accession Number:
0000899243-20-030331
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-03 20:09:17
Reporting Period:
2020-11-03
Accepted Time:
2020-11-03 20:09:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593899 Atea Pharmaceuticals Inc. AVIR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1273885 M Franklin Berger 125 Summer Street
Boston MA 02110
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-03 759,606 $0.00 778,353 No 4 C Direct
Common Stock Acquisiton 2020-11-03 41,666 $24.00 820,019 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2020-11-03 400,000 $0.00 400,000 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2020-11-03 132,014 $0.00 132,014 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2020-11-03 131,578 $0.00 131,578 $0.00
Common Stock Series D Convertible Preferred Stock Disposition 2020-11-03 60,540 $0.00 60,540 $0.00
Common Stock Series D-1 Convertible Preferred Stock Disposition 2020-11-03 35,474 $0.00 35,474 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.